Polymorphisms of cancer stem cell marker gene CD133 are associated with susceptibility and prognosis of gastric cancer.
Future Oncol
; 13(11): 979-989, 2017 May.
Article
in En
| MEDLINE
| ID: mdl-28326835
ABSTRACT
AIM:
This study was aimed to investigate the associations between single nucleotide polymorphisms of cancer stem cell marker genes, CD44 and CD133, and susceptibility and prognosis of gastric cancer. PATIENTS &METHODS:
Five single nucleotide polymorphisms in CD44 and CD133 genes were genotyped in 898 gastric cancer cases and 992 controls.RESULTS:
The A/C or C/C genotypes of CD133 rs2240688 were associated with decreased risk of gastric cancer comparing with the A/A genotype (odds ratio 0.81; 95% CI 0.67-0.97; p = 0.023). The T allele of CD133 rs3130 predicted a worse survival for gastric cancer patients receiving tumorectomy (hazard ratio 1.28; 95% CI 1.04-1.58; p = 0.020), independent from tumor node metastasis stage, vessel invasion and postoperational chemotherapy.CONCLUSION:
CD133 polymorphisms are promising biomarkers for genetic susceptibility and prognosis prediction of gastric cancer.Key words
Full text:
1
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Neoplastic Stem Cells
/
Biomarkers, Tumor
/
Genetic Predisposition to Disease
/
Polymorphism, Single Nucleotide
/
AC133 Antigen
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Future Oncol
Year:
2017
Type:
Article